Teva’s Partner Antares Swallowed Up By Halozyme In $960m Deal

Teva/Antares Alliance Offers Gx EpiPen; US Forteo Rival Under Development

 
• By Dean Rudge
  
Handshake
the transaction is expected to close in the first half of 2022 • Source: Shutterstock: LuckyStep
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business